More on BSE/vCJD

Beale A.J. BSE and vCJD: what is the future? J R Soc Med 2001; 94: 207–9

Brown D.R. , Hafiz F. , Glassmith L.L. Consequences of manganese replacement of copper for prion protein function and proteinase resistance. EMBO J 2000; 19: 1080–2

Wong B.S. , Chen S.G. , Colucci M. Aberrant metal binding by prion protein in human prion disease. J Neurochem 2001; 78: 1400–8

Saborio G.P. , Permanne B. , Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411: 810–13

Ironside J.W. , Hilton D.A. , Ghani A. Retrospective study of prion protein accumulation in tonsil and appendix tissues. Lancet 2000; 355: 1693–4

Bacchetti P. Unexamined assumptions in explorations of upper limit for cases of variant Creutzfeldt–Jakob disease. Lancet 2001; 357: 3–4

Venters G.A. New variant Creutzfeldt–Jakob disease: the epidemic that never was. BMJ 2001; 323: 858–61